Daily Intelligence Brief
Depo-Provera Filing Velocity Quadruples Talc As Paraquat Resurges In Illinois Federal Court
The Depo-Provera Products Liability Litigation (MDL 3140) (N.D. Fla., Judge M. Casey Rodgers) maintained its dominance of federal mass tort dockets with 552 new filings in the past week — a velocity more than four times that of the Johnson & Johnson Talc Litigation (MDL 2738) (D.N.J.), which added 125 complaints despite its massive roughly 67,283 pending action base. The Paraquat Products Liability Litigation (MDL 3004) (S.D. Ill.) showed unexpected renewed activity with 18 new Parkinson's disease claims, including Sanders v. Syngenta Crop Protection LLC (3:26-pq-00367) and Kerker v. Syngenta Crop Protection LLC (3:26-pq-00368), breaking a months-long lull in coordinated filings. The Hair Relaxer Marketing, Sales Practices and Products Liability Litigation (MDL 3060) (N.D. Ill.) contributed 32 new uterine cancer claims, while the Social Media Adolescent Addiction Litigation (MDL 3047) (N.D. Cal., Judge Yvonne Gonzalez Rogers) added 31 filings as that docket processes the aftermath of last week's landmark plaintiff verdict.Nevro Spinal Stimulator MDL Takes Shape As Coordinated California Filings Signal Centralization Push
A concentrated wave of spinal cord stimulator failure complaints against Nevro Corporation has landed in California federal court, signaling momentum toward a potential new MDL for the HF10 therapy device. Eight new filings since March 23 — including Hawken v. Nevro Corporation (3:26-cv-02522) and Manley v. Nevro Corporation (4:26-cv-02507) — allege Nevro's high-frequency stimulation devices caused nerve damage, paralysis, and revision surgeries. The filings arrive as the Spinal Stimulators Litigation (MDL 3181) takes early shape, with practitioners watching whether Judge Gonzalez Rogers or another California jurist receives the centralization petition. Nevro faces parallel pressure from Medtronic device claims, with Geest v. Medtronic, Inc. (1:26-cv-03316) filed in Illinois federal court March 25, suggesting the broader neuromodulation device category may fragment across multiple MDLs or consolidate under a single umbrella.Roblox Child Safety Litigation Expands With Federal Filing As Platform Faces Parallel Regulatory Scrutiny
The Roblox Corporation Child Safety Litigation (MDL 3166) (N.D. Cal.) absorbed a new federal complaint March 27 as Duncan v. Roblox Corporation (3:26-cv-02716) joined the emerging docket alleging the gaming platform facilitated child exploitation and inadequate content moderation. The filing lands amid intensifying regulatory pressure on Roblox, with state attorneys general and the FTC examining the company's child protection protocols following reports of inappropriate content exposure. The MDL — still in early coordination before Judge Gonzalez Rogers — remains smaller than the parallel Social Media Adolescent Addiction Litigation but shares overlapping theories of algorithmic design harm and deficient age verification. Practitioners are watching whether Roblox will seek early dismissal on Section 230 grounds or engage in the same discovery battles over internal safety documents that have defined the Meta and Google proceedings.Generated by LexGenius Feed. Signals sourced from PACER federal court dockets, FDA/OpenFDA adverse event database, Federal Register, PubMed, and Google News.
